A Hierarchical 3D Nanostructured Microfluidic Device for Sensitive Detection of Pathogenic Bacteria

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Microfluidics

Background:

• Early detection of bacterial infections is crucial for patient survival.
• Current diagnostic methods can be slow and lack sensitivity.
• Advanced detection platforms are needed for rapid and accurate bacterial identification.

Purpose of the Study:

• To develop a universal nano/microfluidic device for sensitive and quantifiable detection of pathogenic bacteria.
• To utilize a 3D nanostructured detection platform for enhanced bacterial capture.
• To demonstrate both probe-free and immunoaffinity detection methods.

Main Methods:

• Fabrication of a nano/microfluidic device integrated with a 3D nanostructured detection platform.
• Surface characterization of the 3D nano-/microisland (NMI) structures.
• Demonstration of probe-free capture of Escherichia coli (E. coli) and immunoaffinity capture of methicillin-resistant-Staphylococcus aureus (MRSA).

Main Results:

• The 3D NMI structures exhibit uniform distribution, spatial orientation, and nanorough protrusions.
• The device achieved a linear detection range of 50 to 10^4 CFU mL^-1.
• Average detection efficiencies of 93% for E. coli (probe-free) and 85% for MRSA (immunoaffinity) were recorded.
• Spatial orientation of NMIs aids quantifiable detection, while nanorough protrusions facilitate probe-free capture.

Conclusions:

• The developed nano/microfluidic device enables sensitive and quantifiable detection of pathogenic bacteria.
• The unique 3D nanostructured platform enhances bacterial capture efficiency.
• The device's ease of fabrication and implementation supports potential for future point-of-care diagnostic applications.